The three-fold increase in free medicine coverage for HIV patients and 4.5-fold increase in the coverage of patients with viral hepatitis C was made possible by cooperation with UNICEF and UNDP. And cooperation with the international organization STOP TB in 2019 will open Kazakhstan patients access to innovative medicine for the treatment of multidrug-resistant tuberculosis.
Increase in free medicine coverage for HIV patients and 4.5 – fold increase in the coverage of patients with viral hepatitis C was made possible by cooperation with UNICEF and UNDP.
The contract with the Stop Tuberculosis Foundation was signed for the first time. Under the contract, Delamanid and Bedaquiline will be purchased, which are effective even for patients who are resistant to medicine traditionally used to treat tuberculosis. In total, it is planned to purchase medicines in the amount of 1 billion KZT, and cover 2.5 thousand patients with treatment.
The contract with the foundation was signed for the first time. Under the contract, contract, Delamanid and Bedaquiline will be purchased which are effective even for patients who are resistant to medicine traditionally used to tuberculosis. In total
The close cooperation of the single distributor with international organizations in the framework of medicine provision began in 2016. Then, thanks to a significant reduction in prices for the purchase of antiretroviral medicine for the treatment of HIV patients through the UNICEF platform, it was possible to increase the coverage of medicine provision for HIV patients from 6 to 18 thousand people. In the following years, the cooperation managed to expand the range of ARV medicine purchased through UNICEF, as well as to supplement it with vaccines.
On February 1, 2018, an agreement was signed between the single distributor and UNDP, which allowed to provide Kazakhstan patients with hepatitis C with the most modern and effective treatment with sofosbuvir and daclatasvir. According to the results of such treatment, the cure rate is up to 95%. At the same time, the purchase of medicine through the UNDP platform made it possible to reduce the cost of medicine by 10 times, and to cover all patients who are currently registered in the dispensary for this disease with treatment. In 2019, cooperation with the UN Development Program is planned to expand.
